SC
FHTX icon

Steven Cohen’s Foghorn Therapeutics FHTX Stock Holding History

Steven Cohen’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,646
Closed -$132K – 4198
2026
Q1 		$132K Sell
27,646
-34,322
-55% -$188K ﹤0.01% 3580
2025
Q4 		$335K Sell
61,968
-309,065
-83% -$1.4M ﹤0.01% 3429
2025
Q3 		$1.81M Sell
371,033
-297,686
-45% -$1.58M ﹤0.01% 1478
2025
Q2 		$3.14M Buy
668,719
+43,502
+7% +$182K 0.01% 1131
2025
Q1 		$2.28M Sell
625,217
-9,544
-2% -$43.5K 0.01% 1204
2024
Q4 		$3M Buy
634,761
+235,059
+59% +$1.71M 0.01% 1105
2024
Q3 		$3.72M Sell
399,702
-6,939
-2% -$50.2K 0.01% 965
2024
Q2 		$2.34M Sell
406,641
-30,728
-7% -$183K 0.01% 1053
2024
Q1 		$2.93M Sell
437,369
-102,631
-19% -$570K 0.01% 1143
2023
Q4 		$3.48M Buy
540,000
+255,145
+90% +$1.1M 0.01% 1042
2023
Q3 		$1.42M Buy
284,855
+5,700
+2% +$43.9K ﹤0.01% 1227
2023
Q2 		$1.97M Buy
+279,155
New +$1.95M 0.01% 1042
2023
Q1 		– Sell
-33,000
Closed -$211K – 2333
2022
Q4 		$211K Sell
33,000
-355,600
-92% -$2.68M ﹤0.01% 1255
2022
Q3 		$3.33M Buy
388,600
+12,600
+3% +$162K 0.01% 830
2022
Q2 		$5.11M Buy
376,000
+370,800
+7,131% +$4.79M 0.02% 698
2022
Q1 		$79K Sell
5,200
-378,272
-99% -$5.19M ﹤0.01% 1079
2021
Q4 		$8.77M Buy
+383,472
New +$5.51M 0.04% 546
2021
Q2 		– Sell
-109,200
Closed -$1.44M – 1033
2021
Q1 		$1.44M Buy
+109,200
New +$1.79M 0.01% 770

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Steven Cohen's FHTX Position: Q2 2026 in Review

Steven Cohen sold out of Foghorn Therapeutics (FHTX) in Q2 2026, closing a stake of 27,646 shares — an estimated $132K sold.

Steven Cohen first reported a position in FHTX in Q1 2021 and held it in 18 quarters. The position peaked at $8.77M in Q4 2021. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Steven Cohen reported no remaining Foghorn Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 27,646 Foghorn Therapeutics shares in Q2 2026, an estimated $132K.
  • Steven Cohen first reported a position in Foghorn Therapeutics in Q1 2021 and held it in 18 quarters.
  • Steven Cohen's Foghorn Therapeutics position peaked at $8.77M in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.